tradingkey.logo
tradingkey.logo
검색

NeuroOne Medical Technologies Corp

NMTC
관심 목록에 추가
4.210USD
-0.390-8.48%
종가 05/15, 16:00ET시세는 15분 지연됩니다
36.29M시가총액
손실P/E TTM

NeuroOne Medical Technologies Corp

4.210
-0.390-8.48%

자세한 내용은 NeuroOne Medical Technologies Corp 회사

NeuroOne Medical Technologies Corporation is a medical technology company. It is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders. It may also pursue applications for other areas such as depression, mood disorders, incontinence and artificial intelligence. Its products include Evo cortical electrode technology for recording, monitoring, and stimulating brain tissue for up to 30 days; Evo sEEG electrode technology for temporary (less than 30 days) use with recording, monitoring, and stimulation equipment for the recording, monitoring, and stimulation of electrical signals at the subsurface level of the brain, and OneRF ablation system for creation of radiofrequency lesions in nervous tissue for functional neurosurgical procedures.

NeuroOne Medical Technologies Corp 정보

종목 코드 NMTC
회사 이름NeuroOne Medical Technologies Corp
상장일Nov 09, 2012
CEORosa (David A)
직원 수17
유형Ordinary Share
회계 연도 종료Nov 09
주소7599 Anagram Dr
도시EDEN PRAIRIE
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호55344-7399
전화19524261383
웹사이트https://nmtc1.com/
종목 코드 NMTC
상장일Nov 09, 2012
CEORosa (David A)

NeuroOne Medical Technologies Corp의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Mr. David A. (Dave) Rosa
Mr. David A. (Dave) Rosa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
123.37K
-0.33%
Mr. Paul Buckman
Mr. Paul Buckman
Independent Chairman of the Board
Independent Chairman of the Board
40.60K
+17.21%
Mr. Mark Christianson
Mr. Mark Christianson
Co-Founder, Business Development Director, Medical Sales Liaison
Co-Founder, Business Development Director, Medical Sales Liaison
33.11K
-15.23%
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Independent Director
Independent Director
24.17K
+28.92%
Mr. Edward (Ed) Andrle
Mr. Edward (Ed) Andrle
Independent Director
Independent Director
22.32K
+31.31%
Mr. Steve Mertens
Mr. Steve Mertens
Chief Technology Officer
Chief Technology Officer
15.43K
-0.98%
Mr. Ronald (Ron) Mcclurg
Mr. Ronald (Ron) Mcclurg
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Christopher R. Volker
Mr. Christopher R. Volker
Chief Operating Officer
Chief Operating Officer
--
--
Ms. Emily Johns
Ms. Emily Johns
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
--
--
Mr. Chris Donovan
Mr. Chris Donovan
Investor Relations
Investor Relations
--
--
이름
이름/직위
직위
주식 보유
변동
Mr. David A. (Dave) Rosa
Mr. David A. (Dave) Rosa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
123.37K
-0.33%
Mr. Paul Buckman
Mr. Paul Buckman
Independent Chairman of the Board
Independent Chairman of the Board
40.60K
+17.21%
Mr. Mark Christianson
Mr. Mark Christianson
Co-Founder, Business Development Director, Medical Sales Liaison
Co-Founder, Business Development Director, Medical Sales Liaison
33.11K
-15.23%
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Independent Director
Independent Director
24.17K
+28.92%
Mr. Edward (Ed) Andrle
Mr. Edward (Ed) Andrle
Independent Director
Independent Director
22.32K
+31.31%
Mr. Steve Mertens
Mr. Steve Mertens
Chief Technology Officer
Chief Technology Officer
15.43K
-0.98%

수익 분석

기업이 아직 관련 데이터를 공개하지 않았습니다.
기업이 아직 관련 데이터를 공개하지 않았습니다.
사업별
지역별
기업이 아직 관련 데이터를 공개하지 않았습니다.

주식 보유 통계

마지막 업데이트: Sun, May 10
마지막 업데이트: Sun, May 10
주주
주주 유형
주주
주주
비율
Merchant Adventure Fund LP
8.12%
Bleichroeder LP
7.73%
Bard Associates Inc.
3.56%
Perkins Capital Management, Inc.
2.85%
Vanguard Capital Management, LLC
2.70%
기타
75.04%
주주
주주
비율
Merchant Adventure Fund LP
8.12%
Bleichroeder LP
7.73%
Bard Associates Inc.
3.56%
Perkins Capital Management, Inc.
2.85%
Vanguard Capital Management, LLC
2.70%
기타
75.04%
주주 유형
주주
비율
Investment Advisor
18.60%
Corporation
8.31%
Individual Investor
5.89%
Hedge Fund
3.86%
Investment Advisor/Hedge Fund
2.13%
Research Firm
0.18%
Venture Capital
0.17%
Bank and Trust
0.04%
기타
60.82%

기관 주식 보유

마지막 업데이트: Wed, Apr 1
마지막 업데이트: Wed, Apr 1
보고 기간
기관 수
보유 주식
비율
변동
2026Q1
58
2.36M
28.07%
-230.40K
2025Q4
52
16.89M
33.49%
-598.07K
2025Q3
51
17.15M
34.30%
+9.56M
2025Q2
52
13.28M
26.66%
+2.81M
2025Q1
54
11.51M
24.26%
+968.46K
2024Q4
55
12.46M
40.67%
+1.38M
2024Q3
55
11.22M
39.84%
+2.23M
2024Q2
51
10.72M
41.07%
+2.35M
2024Q1
52
11.45M
45.01%
+2.75M
2023Q4
57
9.37M
38.68%
+871.77K
더 보기

주주 활동

이름
보유 주식
비율
변동
Chg %
날짜
Merchant Adventure Fund LP
4.20M
8.29%
--
--
Dec 31, 2025
Bleichroeder LP
4.00M
7.89%
--
--
Dec 31, 2025
Bard Associates Inc.
1.85M
3.64%
-4.00K
-0.22%
Dec 31, 2025
Perkins Capital Management, Inc.
1.47M
2.91%
+5.00K
+0.34%
Dec 31, 2025
Sio Capital Management, LLC
1.14M
2.25%
-1.22M
-51.71%
Dec 31, 2025
Renaissance Technologies LLC
763.03K
1.51%
+70.43K
+10.17%
Dec 31, 2025
Rosa (David A)
745.12K
1.47%
-71.33K
-8.74%
Feb 18, 2026
Geode Capital Management, L.L.C.
504.51K
1%
+7.68K
+1.54%
Dec 31, 2025
더 보기

관련 ETF

이름
비율
데이터 없음

주식 배당금

지난 5년 동안 총 0.00 USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음

주식 분할

날짜
배당락일
유형
비율
Apr 14, 2026
Merger
6→1
날짜
배당락일
유형
비율
Apr 14, 2026
Merger
6→1
KeyAI